Stock listing
NASDAQ:BMRA Biomerica, Inc. Stock
Home listing (NASDAQ) of Biomerica, Inc.
Follow Biomerica, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:BMRA
$1.08 USD -0.01 (-0.9%)
Close on Nov 20, 2026
- Day range
- $1.06 – $1.13 USDNov 20, 2026
- Volume
- 5,382 sharesNov 20, 2026
- Market cap
- $4.97M USDAt the close on Nov 20, 2026 · price × 4.60M shares outstanding
- 52-week range
- $1.01 – $2.94 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $151,332 USDMedian day 13,300 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BMRA · Home | $1.08 USD | -0.01 (-0.9%) | 5,382 | $1.13 | $1.13 | $1.06 | $1.09 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BMRA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.08 | -0.01 | -0.9% | $1.13 | $1.13 | $1.06 | 5,382 | |
| $1.09 | -0.145 | -11.7% | $1.20 | $1.22 | $1.05 | 14,650 | |
| $1.235 | -0.085 | -6.4% | $1.29 | $1.333 | $1.01 | 15,586 | |
| $1.32 | -0.04 | -2.9% | $1.36 | $1.37 | $1.32 | 8,523 | |
| $1.36 | +0.06 | +4.6% | $1.33 | $1.39 | $1.33 | 6,012 | |
| $1.30 | -0.21 | -13.9% | $1.52 | $1.52 | $1.27 | 30,417 | |
| $1.51 | +0.03 | +2.0% | $1.50 | $1.58 | $1.48 | 6,624 | |
| $1.48 | -0.07 | -4.5% | $1.53 | $1.69 | $1.48 | 14,471 | |
| $1.55 | -0.06 | -3.7% | $1.55 | $1.62 | $1.53 | 20,680 | |
| $1.61 | 0.00 | 0.0% | $1.66 | $1.78 | $1.585 | 9,073 | |
| $1.61 | -0.125 | -7.2% | $1.63 | $1.70 | $1.55 | 17,100 | |
| $1.735 | +0.035 | +2.1% | $1.691 | $1.79 | $1.646 | 12,115 | |
| $1.70 | -0.03 | -1.7% | $1.707 | $1.75 | $1.70 | 5,946 | |
| $1.73 | +0.01 | +0.6% | $1.772 | $1.772 | $1.715 | 2,881 | |
| $1.72 | -0.02 | -1.1% | $1.695 | $1.735 | $1.68 | 10,215 | |
| $1.74 | -0.01 | -0.6% | $1.705 | $1.749 | $1.70 | 4,174 | |
| $1.75 | +0.04 | +2.3% | $1.72 | $1.771 | $1.705 | 3,879 | |
| $1.71 | -0.01 | -0.6% | $1.774 | $1.78 | $1.66 | 7,063 | |
| $1.72 | +0.04 | +2.4% | $1.67 | $1.79 | $1.67 | 10,412 | |
| $1.68 | 0.00 | 0.0% | $1.68 | $1.72 | $1.66 | 12,000 | |
| $1.68 | -0.03 | -1.8% | $1.66 | $1.71 | $1.66 | 2,000 | |
| $1.71 | -0.01 | -0.6% | $1.69 | $1.72 | $1.60 | 7,500 | |
| $1.72 | -0.04 | -2.3% | $1.77 | $1.79 | $1.60 | 6,000 | |
| $1.76 | -0.09 | -4.9% | $1.85 | $1.85 | $1.75 | 13,300 | |
| $1.85 | -0.03 | -1.6% | $1.83 | $1.95 | $1.81 | 13,200 | |
| $1.88 | +0.08 | +4.4% | $1.87 | $1.92 | $1.81 | 13,800 | |
| $1.80 | -0.05 | -2.7% | $1.83 | $1.86 | $1.76 | 18,600 | |
| $1.85 | +0.01 | +0.5% | $1.85 | $1.89 | $1.81 | 13,300 | |
| $1.84 | 0.00 | 0.0% | $1.90 | $1.90 | $1.84 | 4,900 | |
| $1.84 | -0.05 | -2.6% | $1.86 | $1.87 | $1.84 | 10,300 | |
| $1.89 | -0.02 | -1.0% | $1.91 | $1.91 | $1.86 | 6,600 | |
| $1.91 | -0.23 | -10.7% | $2.10 | $2.10 | $1.90 | 34,700 | |
| $2.14 | +0.09 | +4.4% | $2.09 | $2.14 | $2.01 | 11,100 | |
| $2.05 | -0.09 | -4.2% | $2.06 | $2.19 | $2.02 | 33,900 | |
| $2.14 | -0.10 | -4.5% | $2.19 | $2.23 | $2.14 | 8,400 | |
| $2.24 | -0.02 | -0.9% | $2.25 | $2.25 | $2.24 | 2,200 | |
| $2.26 | -0.04 | -1.7% | $2.32 | $2.34 | $2.25 | 11,400 | |
| $2.30 | -0.09 | -3.8% | $2.35 | $2.35 | $2.30 | 2,500 | |
| $2.39 | +0.07 | +3.0% | $2.30 | $2.39 | $2.29 | 7,100 | |
| $2.32 | -0.14 | -5.7% | $2.43 | $2.64 | $2.18 | 58,600 | |
| $2.46 | -0.15 | -5.7% | $2.60 | $2.64 | $2.44 | 51,000 | |
| $2.61 | -0.17 | -6.1% | $2.79 | $2.84 | $2.58 | 37,600 | |
| $2.78 | +0.18 | +6.9% | $2.60 | $2.78 | $2.57 | 42,000 | |
| $2.60 | +0.09 | +3.6% | $2.55 | $2.60 | $2.41 | 23,100 | |
| $2.51 | +0.15 | +6.4% | $2.34 | $2.52 | $2.30 | 75,800 | |
| $2.36 | -0.01 | -0.4% | $2.31 | $2.41 | $2.26 | 37,500 | |
| $2.37 | +0.07 | +3.0% | $2.27 | $2.42 | $2.27 | 13,700 | |
| $2.30 | -0.06 | -2.5% | $2.36 | $2.39 | $2.28 | 17,500 | |
| $2.36 | +0.12 | +5.4% | $2.26 | $2.41 | $2.18 | 28,100 | |
| $2.24 | +0.01 | +0.4% | $2.25 | $2.29 | $2.13 | 11,900 | |
| $2.23 | -0.04 | -1.8% | $2.17 | $2.25 | $2.17 | 15,400 | |
| $2.27 | -0.07 | -3.0% | $2.35 | $2.35 | $1.97 | 21,400 | |
| $2.34 | +0.03 | +1.3% | $2.27 | $2.38 | $2.21 | 85,200 | |
| $2.31 | +0.09 | +4.1% | $2.27 | $2.35 | $2.21 | 54,400 | |
| $2.22 | +0.02 | +0.9% | $2.21 | $2.33 | $2.17 | 58,900 | |
| $2.20 | +0.11 | +5.3% | $2.05 | $2.20 | $1.98 | 67,700 | |
| $2.09 | 0.00 | 0.0% | $2.11 | $2.15 | $1.94 | 34,400 | |
| $2.09 | -0.05 | -2.3% | $2.15 | $2.16 | $2.01 | 51,100 | |
| $2.14 | +0.04 | +1.9% | $2.13 | $2.15 | $2.01 | 131,900 | |
| $2.10 | +0.41 | +24.3% | $1.71 | $2.35 | $1.71 | 3,273,300 | |
| $1.69 | -0.08 | -4.5% | $1.70 | $1.78 | $1.69 | 8,500 | |
| $1.77 | +0.09 | +5.4% | $1.66 | $1.81 | $1.66 | 16,800 | |
| $1.68 | +0.07 | +4.3% | $1.61 | $1.69 | $1.60 | 8,500 | |
| $1.61 | +0.02 | +1.3% | $1.58 | $1.63 | $1.58 | 10,000 | |
| $1.59 | +0.07 | +4.6% | $1.55 | $1.59 | $1.52 | 3,500 |
Splits
2 splits since 1994 · NASDAQ:BMRA · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-8 | Consolidation | |
| 1-for-2 | Consolidation |
- Ticker
- NASDAQ:BMRA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 16, 2026
Biomerica Reports First Quarter Fiscal 2027 Financial Results
Latest deck · March 2026
Investor Presentation (March 2026)
Investor deck · 26 slides
Latest news
Biomerica Reports First Quarter Fiscal 2027 Financial Results
Oct 16, 2026
Closed $1.85 (-1.6%) on Oct 16, 2026
Biomerica Reports Fiscal 2026 Year-End Financial Results
Sep 1, 2026
Closed $2.09 (0.0%) on Sep 1, 2026
Annual Report for Fiscal Year Ending May 31, 2026 (Form 10-K)
Aug 31, 2026
Closed $2.09 (0.0%) on Sep 1, 2026
Biomerica Announces $2.23 Million Financing
Aug 28, 2026
Closed $2.14 (+1.9%) on Aug 28, 2026
Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
May 28, 2026
Closed $2.43 (-1.2%) on May 28, 2026
Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026
Apr 29, 2026
Closed $2.16 (-0.9%) on Apr 29, 2026
Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods IBS, Opening a Scalable Medicare Commercialization Pathway
Apr 17, 2026
Closed $2.18 (-0.9%) on Apr 17, 2026
Biomerica Launches inFoods IBS in Canada through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs
Apr 15, 2026
Closed $2.11 (+0.5%) on Apr 15, 2026
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
Apr 13, 2026
Closed $2.08 (-2.3%) on Apr 13, 2026
Biomerica Receives First Commercial Order for its H. pylori test from one of the Largest Clinical Laboratory Chains in Europe
Mar 19, 2026
Closed $2.08 (-2.8%) on Mar 19, 2026
Biomerica, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 21 in the last 12 months · 101 in all · newest Oct 16, 2026 · oldest 2019
- Decks
- 21 decks · latest March 2026
Where Biomerica, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BMRA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:BMRA | BOATS | United States | USD |
Valuation
EV/sales 0.5× against a median of 0.7×: 4th lowest of 10 Diagnostics & research services companies shown. Statements: 4 quarters to Aug 31, 2026 · price Nov 20, 2026
- Enterprise value
- $2.23M USD
- P/E
- Loss
- EV/sales
- 0.5×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 1.4×
- Gross margin
- 0.9%
- Operating margin
- −125.2%
- Net margin
- −115.5%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.71
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Biomerica, Inc. · NASDAQ:BMRA | US$4.97M | US$2.23M | n/a | 0.5× | n/a | 1.4× | −115.5% | 0.0× | 0.71 |
| GENinCode PLC · LSE:GENI | US$5.42M | US$2.86M | n/a | 0.7× | n/a | 2.0× | −185.5% | 0.1× | n/a |
| Nanologica AB · OMXSTO:NICA | US$5.29M | US$8.67M | 2.9× | 1.6× | n/a | 0.3× | 34.9% | 0.3× | n/a |
| VivoSim Labs, Inc. · NASDAQ:VIVS | US$5.29M | −US$2.76M | n/a | −20.5× | n/a | 0.7× | n/a | 0.1× | 1.91 |
| VolitionRx Limited · AMEX:VNRX | US$4.87M | US$9.19M | n/a | 2.7× | n/a | n/a | −698.5% | n/a | 1.52 |
| Boule Diagnostics AB · OMXSTO:BOUL | US$4.84M | US$24.70M | n/a | 0.6× | n/a | 0.3× | −4.0% | 1.3× | n/a |
| BioInfra Co.,Ltd. · KRX:199730 | US$4.75M | −US$509,202 | n/a | −0.0× | n/a | 0.5× | −32.3% | 0.0× | n/a |
| Cardio Diagnostics Holdings Inc. · NASDAQ:CDIO | US$4.74M | US$4.74M | n/a | 312× | n/a | 0.8× | n/a | 0.0× | 2.07 |
| Niki BioSolutions, Inc. · NASDAQ:NIKI | US$4.61M | US$4.60M | n/a | n/a | n/a | 0.2× | n/a | 0.1× | 1.46 |
| Cambridge Nutritional Sciences PLC · LSE:CNSL | US$4.51M | US$1.23M | n/a | 0.1× | n/a | 0.6× | −83.5% | 0.0× | n/a |
| Proteome Sciences plc · LSE:PRM | US$4.45M | US$23.87M | n/a | 4.9× | n/a | n/a | −81.5% | n/a | n/a |
| Median of the others | US$4.80M | US$4.67M | 2.9× | 0.7× | 0.6× | −81.5% | 0.1× | 1.72 |
Team and board
Officers
| Officer | Role |
|---|---|
| David Moatazedi | President and Chief Executive Officer |
| Gary M. Huff | Healthcare Executive and Board Director |
Board
| Director | Role |
|---|---|
| David Moatazedi | President and Chief Executive Officer |
| Eric Chin | Independent Director |
| Gary M. Huff | Healthcare Executive and Board Director |
Events
- Next results
- Jan 13, 2027 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Q1 2027 | Oct 15, 2026 | +2.8% |
| Q4 2026 | Aug 31, 2026 | −2.3% |
| Q3 2026 | Apr 14, 2026 | +1.4% |
| Q2 2026 | Jan 14, 2026 | −1.1% |
| Q1 2026 | Oct 13, 2025 · After close | +2.9% |
| Q4 2025 | Aug 29, 2025 | −5.1% |
| Q3 2025 | Apr 10, 2025 · Before open | −5.6% |
| Q2 2025 | Jan 14, 2025 · Before open | +3.1% |
| Q1 2025 | Oct 15, 2024 · After close | +9.4% |
| Q4 2024 | Aug 28, 2024 · After close | 0.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2024 | Apr 12, 2024 · After close | −7.2% |
| Q2 2024 | Jan 16, 2024 · Before open | +2.1% |
| Q1 2024 | Oct 12, 2023 · After close | −1.3% |
| Q4 2023 | Aug 25, 2023 · After close | +4.3% |
| Q3 2023 | Apr 14, 2023 · After close | +3.0% |
| Q2 2023 | Jan 13, 2023 · After close | −1.3% |
| Q1 2023 | Oct 13, 2022 · After close | −6.6% |
| Q4 2022 | Aug 29, 2022 · After close | +4.1% |
| Q3 2022 | Apr 14, 2022 · Before open | +3.5% |
| Q2 2022 | Jan 12, 2022 · After close | −7.6% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2026) | Investor deck | 26 slides | March 2026 |
| Investor Presentation (February 2026) | Investor deck | 27 slides | February 2026 |
| Investor Presentation (September 2025) | Investor deck | 29 slides | September 2025 |
| Investor Presentation (July 2025) | Investor deck | 30 slides | July 2025 |
| Investor Presentation (November 2024) | Investor deck | 32 slides | November 2024 |
| Investor Presentation (September 2024) | Investor deck | 31 slides | September 2024 |
| Investor Presentation (May 2024) | Investor deck | 30 slides | May 2024 |
| Investor Presentation (December 2023) | Investor deck | 30 slides | December 2023 |
| Investor Presentation (June 2023) | Investor deck | 30 slides | June 2023 |
| Investor Presentation (April 2023) | Investor deck | 29 slides | Apr 25, 2023 |
All 21 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (February 2023) | Investor deck | 29 slides | February 2023 |
| Investor Presentation (January 2023) | Investor deck | 30 slides | January 2023 |
| Investor Presentation (October 2022) | Investor deck | 30 slides | October 2022 |
| Investor Presentation (February 2022) | Investor deck | 23 slides | February 2022 |
| Investor Presentation (November 2021) | Investor deck | 23 slides | November 2021 |
| Investor Presentation (September 2021) | Investor deck | 22 slides | September 2021 |
| Investor Presentation (September 2020) | Investor deck | 22 slides | Sep 2, 2020 |
| Investor Presentation (January 2020) | Investor deck | 27 slides | Jan 9, 2020 |
| Investor Presentation (September 2018) | Investor deck | 26 slides | Sep 28, 2018 |
| Investor Presentation (September 2016) | Investor deck | 26 slides | Sep 12, 2016 |
| Investor Presentation (March 2016) | Investor deck | 18 slides | Mar 16, 2016 |
Financings
| Raise | Date |
|---|---|
| Private placement of shares of common stock Closed: US$2.23M raised · US$1.6 a share Buyers: B. Riley Principal Capital; Executives and employees of B. Riley Securities, Inc.; Chief Executive Officer; Board of Directors (all members of the Company's Board of Directors); B. Riley Principal Capital, LLC; Biomerica Board of Directors (all members participated) Insiders: All members of Biomerica's Board of Directors participated Use of proceeds: Strengthen the balance sheet and fund operations while the Board evaluates potential strategic opportunities | Sep 1, 2026 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.45M | 5.31M | 5.42M | 5.34M | 18.9M | 7.20M | 6.69M | 5.20M | 5.56M | 5.79M |
| Cost of revenue | 4.09M | 4.81M | 4.80M | 4.89M | 15.9M | 6.83M | 4.95M | 3.91M | 3.81M | 3.77M |
| Gross profit | 362.0K | 498.0K | 611.0K | 446.0K | 2.98M | 366.3K | 1.74M | 1.29M | 1.75M | 2.02M |
| Research and development | 788.0K | 1.02M | 1.49M | 1.58M | 1.81M | 2.19M | 1.93M | 1.68M | 1.40M | 1.13M |
| Selling, general and administrative | 4.89M | 4.61M | 5.49M | 6.08M | 5.70M | 5.67M | 2.55M | 2.03M | 1.84M | 1.85M |
| Operating income | -5.32M | -5.14M | -6.37M | -7.22M | -4.53M | -7.50M | -2.74M | -2.41M | -1.48M | -954.6K |
| Depreciation and amortization | 77.0K | 87.0K | 81.0K | 84.0K | 339.0K | 105.0K | 105.3K | 101.2K | 111.1K | 144.9K |
| EBITDA | -5.24M | -5.05M | -6.29M | -7.14M | -4.20M | -7.39M | -2.64M | -2.31M | -1.37M | -809.7K |
| Interest expense | 367 | 9 | 47 | 37 | 282 | |||||
| Income before tax | -3.75M | -4.97M | -5.94M | -7.09M | -4.51M | -7.43M | -2.67M | -2.37M | -1.43M | -908.6K |
| Income tax | 23.0K | 1.00K | 42.0K | 51.0K | 24.0K | 13.1K | 7.39K | 24.2K | 31.8K | |
| Net income | -3.77M | -4.97M | -5.98M | -7.14M | -4.53M | -7.45M | -2.68M | -2.39M | -1.47M | -908.6K |
| Earnings per share, basic | -1.30 | -2.16 | -2.84 | -0.50 | -0.36 | -0.62 | -0.26 | -0.26 | -0.17 | -0.11 |
| Earnings per share, diluted | -1.30 | -2.16 | -2.84 | -0.50 | -0.36 | -0.62 | -0.26 | -0.26 | -0.17 | -0.11 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.31M | 2.40M | 4.17M | 9.72M | 5.92M | 4.20M | 8.64M | 686.8K | 1.20M | 1.23M |
| Receivables | 785.0K | 731.0K | 947.0K | 722.0K | 774.0K | 1.46M | 1.77M | 1.45M | 799.9K | 1.06M |
| Inventory | 1.71M | 1.49M | 2.38M | 2.06M | 2.42M | 3.21M | 2.85M | 2.15M | 2.18M | 1.73M |
| Current assets | 4.02M | 4.88M | 7.73M | 12.8M | 9.43M | 9.23M | 14.8M | 4.49M | 4.48M | 4.21M |
| Property, plant and equipment | 78.0K | 135.0K | 201.0K | 213.0K | 214.0K | 310.5K | 279.4K | 351.1K | 351.1K | 331.9K |
| Total assets | 6.76M | 5.95M | 9.25M | 14.5M | 11.4M | 11.8M | 17.3M | 5.25M | 5.22M | 5.02M |
| Accounts payable | 377.0K | 295.0K | 560.0K | 344.0K | 736.0K | 431.0K | 833.4K | 999.6K | 336.4K | |
| Current liabilities | 2.48M | 1.74M | 2.20M | 1.95M | 2.01M | 1.30M | 1.48M | 1.26M | 896.8K | 528.9K |
| Total liabilities | 4.13M | 1.84M | 2.66M | 2.73M | 3.05M | 2.59M | 3.05M | 1.26M | ||
| Shareholders' equity | 2.63M | 4.11M | 6.59M | 11.7M | 8.32M | 9.23M | 14.2M | 3.98M | 4.33M | 4.49M |
| Shares outstanding | 3.20M | 2.55M | 2.10M | 16.8M | 12.9M | 12.3M | 11.7M | 9.68M | 8.89M | 8.51M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -3.42M | -3.84M | -5.36M | -5.47M | -479.0K | -5.25M | -4.30M | -2.24M | -1.17M | -722.9K |
| Capital spending | -51.0K | -64.0K | -57.0K | -135.9K | -33.6K | -101.1K | -130.3K | -96.1K | ||
| Free cash flow | -5.41M | -5.54M | -536.0K | -5.39M | -4.33M | -2.35M | -1.30M | -818.9K | ||
| Cash from investing | -1.00K | -37.0K | -115.0K | -78.0K | -170.0K | -295.6K | -118.9K | -171.1K | -130.3K | -96.1K |
| Cash from financing | 2.33M | 2.11M | -81.0K | 9.39M | 2.39M | 1.11M | 12.4M | 1.91M | 1.29M | 157.7K |
| Change in cash | -1.09M | -1.77M | -5.55M | 3.80M | 1.72M | -4.44M | 7.95M | -518.1K | -20.6K | -663.5K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| DEF 14A · Proxy statement | Oct 16, 2026 | Meeting notice | SEC |
| 10-Q · Quarterly report | Oct 15, 2026 | Quarterly report | SEC |
| 8-K · Current report | Oct 15, 2026 | Management or board change | SEC |
| EFFECT · Notice that a registration is effective | Oct 8, 2026 | Other filings | SEC |
| EFFECT · Notice that a registration is effective | Oct 8, 2026 | Other filings | SEC |
| 10-K/A · Annual report, amended | Sep 28, 2026 | Annual report | SEC |
| S-3 · Registration statement | Sep 25, 2026 | Offer document | SEC |
| S-3 · Registration statement | Sep 24, 2026 | Offer document | SEC |
| 3 · Initial statement of ownership | Sep 10, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 8, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-K · Annual report | Aug 31, 2026 | Annual report | SEC |
| SCHEDULE 13D · Big-stake notice | Aug 28, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 27, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 26, 2026 | Material contract | SEC |
| 8-K · Current report | Jun 4, 2026 | Material contract | SEC |
| 10-Q · Quarterly report | Apr 13, 2026 | Quarterly report | SEC |
| S-8 · Registration statement for employee plans | Feb 27, 2026 | Offer document | SEC |
| 4 · Change in ownership | Jan 28, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Jan 14, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Dec 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 31, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 16, 2025 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Oct 23, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Oct 20, 2025 | Meeting notice | SEC |
| 10-Q · Quarterly report | Oct 14, 2025 | Quarterly report | SEC |
| PRE 14A · Preliminary proxy statement | Oct 9, 2025 | Meeting notice | SEC |
| 8-K · Current report | Oct 8, 2025 | Management or board change | SEC |
| 10-K/A · Annual report, amended | Sep 26, 2025 | Annual report | SEC |
| 10-K · Annual report | Aug 29, 2025 | Annual report | SEC |
| 8-K · Current report | Jun 6, 2025 | Management or board change | SEC |
| 3 · Initial statement of ownership | Jun 6, 2025 | Insider trade | SEC |
| 8-K · Current report | Apr 16, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Apr 14, 2025 | Quarterly report | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 11, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Jan 14, 2025 | Quarterly report | SEC |
| S-8 · Registration statement for employee plans | Dec 20, 2024 | Offer document | SEC |
| 4 · Change in ownership | Dec 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2024 | Insider trade | SEC |
| 8-K · Current report | Dec 17, 2024 | Meeting outcome | SEC |
| S-8 · Registration statement for employee plans | Nov 25, 2024 | Offer document | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Nov 6, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Oct 15, 2024 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Sep 30, 2024 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Sep 20, 2024 | Meeting notice | SEC |
| 10-K · Annual report | Aug 28, 2024 | Annual report | SEC |
| 5 · Annual statement of ownership | Jul 3, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 28, 2024 | Management or board change | SEC |
| 424B5 · Prospectus | May 10, 2024 | Offer document | SEC |
| 8-K · Current report | May 10, 2024 | Material contract | SEC |
| 10-Q · Quarterly report | Apr 12, 2024 | Quarterly report | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Feb 9, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Jan 16, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Dec 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 11, 2023 | Meeting outcome | SEC |
| 4 · Change in ownership | Dec 11, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Oct 12, 2023 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Oct 2, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Sep 29, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 29, 2023 | Other filings | SEC |
| S-3 · Registration statement | Sep 27, 2023 | Offer document | SEC |
| DEF 14A · Proxy statement | Sep 27, 2023 | Meeting notice | SEC |
| 8-K · Current report | Sep 19, 2023 | Current report | SEC |
| 3 · Initial statement of ownership | Aug 29, 2023 | Insider trade | SEC |
| 8-K · Current report | Aug 28, 2023 | Management or board change | SEC |
| 10-K · Annual report | Aug 25, 2023 | Annual report | SEC |
| 3 · Initial statement of ownership | Aug 18, 2023 | Insider trade | SEC |
| 8-K · Current report | Jul 26, 2023 | Current report | SEC |
| 5 · Annual statement of ownership | Jul 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 27, 2023 | Insider trade | SEC |
| 8-K · Current report | Apr 25, 2023 | Current report | SEC |
| 10-Q · Quarterly report | Apr 14, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | Apr 10, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 9, 2023 | Insider trade | SEC |
| 8-K · Current report | Mar 7, 2023 | Material contract | SEC |
| 424B5 · Prospectus | Mar 6, 2023 | Offer document | SEC |
| 424B5 · Prospectus | Mar 2, 2023 | Offer document | SEC |
| 424B5 · Prospectus | Mar 2, 2023 | Offer document | SEC |
| 8-K · Current report | Mar 2, 2023 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Feb 7, 2023 | Current report | SEC |
| 4 · Change in ownership | Jan 31, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 25, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Jan 13, 2023 | Quarterly report | SEC |
| 8-K/A · Current report, amended | Dec 29, 2022 | Meeting outcome | SEC |
| 8-K · Current report | Dec 16, 2022 | Management or board change | SEC |
| 8-K · Current report | Dec 16, 2022 | Management or board change | SEC |
| 8-K · Current report | Dec 9, 2022 | Meeting outcome | SEC |
| 8-K · Current report | Dec 9, 2022 | Management or board change | SEC |
| 8-K · Current report | Nov 14, 2022 | Current report | SEC |
| 10-Q · Quarterly report | Oct 13, 2022 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Sep 27, 2022 | Meeting notice | SEC |
| 10-K · Annual report | Aug 29, 2022 | Annual report | SEC |
| 5 · Annual statement of ownership | Jun 24, 2022 | Insider trade | SEC |
| 8-K · Current report | Apr 19, 2022 | Current report | SEC |
| 10-Q · Quarterly report | Apr 14, 2022 | Quarterly report | SEC |
| SC 13G · Big-stake notice | Feb 14, 2022 | Big-stake notice | SEC |
| 8-K · Current report | Feb 10, 2022 | Current report | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 4, 2022 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 4, 2022 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 4, 2022 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Jan 12, 2022 | Quarterly report | SEC |
| 8-K · Current report | Dec 16, 2021 | Results | SEC |
| 4 · Change in ownership | Dec 10, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2021 | Insider trade | SEC |
| 8-K · Current report | Dec 10, 2021 | Meeting outcome | SEC |
| 8-K · Current report | Dec 7, 2021 | Current report | SEC |
| 10-Q · Quarterly report | Oct 14, 2021 | Quarterly report | SEC |
| 10-K/A · Annual report, amended | Oct 14, 2021 | Annual report | SEC |
| 8-K · Current report | Sep 30, 2021 | Current report | SEC |
| DEF 14A · Proxy statement | Sep 28, 2021 | Meeting notice | SEC |
| 10-K · Annual report | Aug 27, 2021 | Annual report | SEC |
| 5/A · Annual statement of ownership, amended | Jun 28, 2021 | Insider trade | SEC |
| 5 · Annual statement of ownership | Jun 25, 2021 | Insider trade | SEC |
| 8-K · Current report | Jun 24, 2021 | Current report | SEC |
| S-8 · Registration statement for employee plans | May 21, 2021 | Offer document | SEC |
| 10-Q · Quarterly report | Apr 14, 2021 | Quarterly report | SEC |
| SC 13G · Big-stake notice | Feb 3, 2021 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 3, 2021 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Feb 3, 2021 | Big-stake notice | SEC |
| 8-K · Current report | Jan 22, 2021 | Current report | SEC |
| 424B5 · Prospectus | Jan 22, 2021 | Offer document | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 20, 2021 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Jan 14, 2021 | Quarterly report | SEC |
| 8-K · Current report | Jan 13, 2021 | Current report | SEC |
| 4 · Change in ownership | Dec 11, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2020 | Insider trade | SEC |
| 8-K · Current report | Dec 11, 2020 | Meeting outcome | SEC |
| 8-K · Current report | Dec 11, 2020 | Management or board change | SEC |
| SC 13G · Big-stake notice | Nov 30, 2020 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 27, 2020 | Insider trade | SEC |
| 10-Q · Quarterly report | Oct 15, 2020 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Oct 1, 2020 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 28, 2020 | Other filings | SEC |
| DEF 14A · Proxy statement | Sep 25, 2020 | Meeting notice | SEC |
| CORRESP · Letter to the SEC | Sep 11, 2020 | Other filings | SEC |
| S-3/A · Registration statement, amended | Sep 11, 2020 | Offer document | SEC |
| CORRESP · Letter to the SEC | Sep 9, 2020 | Other filings | SEC |
| 3 · Initial statement of ownership | Sep 3, 2020 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 3, 2020 | Insider trade | SEC |
| 8-K · Current report | Sep 1, 2020 | Management or board change | SEC |
| 8-K · Current report | Sep 1, 2020 | Current report | SEC |
| 10-K · Annual report | Aug 31, 2020 | Annual report | SEC |
| UPLOAD · Letter from the SEC | Jul 28, 2020 | Other filings | SEC |
| S-3 · Registration statement | Jul 21, 2020 | Offer document | SEC |
| 8-K · Current report | Jun 29, 2020 | Current report | SEC |
| 8-K · Current report | Jun 16, 2020 | Current report | SEC |
| 8-K · Current report | Jun 1, 2020 | Current report | SEC |
| 8-K · Current report | May 8, 2020 | Current report | SEC |
| 4 · Change in ownership | Apr 21, 2020 | Insider trade | SEC |
| 10-Q · Quarterly report | Apr 14, 2020 | Quarterly report | SEC |
| 8-K · Current report | Apr 6, 2020 | Material contract | SEC |
| 4 · Change in ownership | Apr 3, 2020 | Insider trade | SEC |
| 8-K · Current report | Mar 20, 2020 | Current report | SEC |
| 424B5 · Prospectus | Mar 20, 2020 | Offer document | SEC |
| 8-K · Current report | Mar 17, 2020 | Current report | SEC |
| SC 13D · Big-stake notice | Mar 4, 2020 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 2, 2020 | Insider trade | SEC |
| D | Feb 27, 2020 | Other filings | SEC |
| 8-K · Current report | Feb 27, 2020 | Material contract | SEC |
This page holds 200 of 605 filings. Open Filings
Cap table
Built by 6ix from Biomerica, Inc.’s releases · as of Sep 28, 2026
- Common shares
- 4,598,968
- Fully diluted
- 4,598,968
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 4,598,968 | Sep 28, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Sep 28, 2026 | 4,598,968 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Catherine Coste Other companies: BioLife Solutions, Inc. (Director · Since at least Mar 18, 2025); Renalytix PLC (Director · Since at least Jul 1, 2023); Minerva Surgical, Inc. (Director · Oct 21, 2021 – Jun 10, 2022 · Past) | Director · Oct 26, 2020 – Dec 13, 2024 · Past |
| David Moatazedi Other companies: Evolus, Inc. Common Stock (President and Chief Executive Officer · Since at least May 6, 2018); Vyome Holdings, Inc. (Director · Mar 13, 2017 – Jul 23, 2019 · Past) | President and Chief Executive Officer · Since at least Dec 7, 2022 |
| Allen Barbieri Other companies: CareTrust REIT, Inc. (Director · May 1, 2019 – Apr 30, 2021 · Past) | Executive Vice Chairman, Director · Since at least Dec 19, 2019 |
| Francis Cano Other companies: Dynavax Technologies Corporation (Director · Since at least Nov 3, 2009) | Director · May 31, 2006 – Dec 10, 2020 · Past |
| M Huff Gary Other companies: Labcorp Holdings Inc. (CEO, LabCorp Diagnostics · Mar 29, 2017 – Sep 4, 2018 · Past) | Director · Since at least Dec 12, 2025 |
| Eric B. Chin | Director · Since at least Jun 6, 2025 |
| Francis E Capitanio | President · Jan 5, 2012 – Jan 22, 2018 · Past |
| Gary Huff | Healthcare Executive and Board Director · Since at least Oct 8, 2025 |
| Gary Lu | Chief Financial Officer · Since at least Mar 1, 2023 |
| Jane Emerson | Director · May 1, 2007 – Dec 13, 2024 · Past |
All 14 people
| Person | Seat |
|---|---|
| Scott Madel | Chief Commercial Officer · Jun 26, 2025 – Nov 5, 2026 · Past |
| Xiaoxuan Qu | See Remarks · Since at least Aug 27, 2026 |
| Zackary S Irani | Chief Executive Officer, Director · Since at least Dec 12, 2025 |
| Zack Irani | CEO · Apr 16, 2026 – Nov 5, 2026 · Past |
Log in to ask 6ix AI your own questions about Biomerica, Inc.